- The trend backdrop is active with a 44-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is constructive, supporting the smart-money activity read.
CRNA
OSL
Week ended 07 Aug 2026
Weekly Investor Report
Circio Holding ASA · Healthcare · Biotechnology
Latest close
8.77 NOK
7.0%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 30.7% above the Trend Line and sits at 59.1% of its 52-week range. The latest completed week returned 7.0%, after a 19.5% four-week move. The latest news-sentiment score is 50/100.
Setup score
61
out of 100
Latest Close
8.77 NOK
7 Aug 2026
1W Return
7.0%
latest completed week
4W Return
19.5%
short-term follow-through
12W Return
-21.1%
quarterly tape
Trend Breadth
84.6%
44 of 52 weeks active
Volume Ratio
1.3x
vs 13-week average
- Activity pressure is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
7.0%
Latest completed week; four-week move 19.5%.
Indicator stack
92/42
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 30.7% above the Trend Line and sits at 59.1% of its 52-week range. The latest completed week returned 7.0%, after a 19.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 1.3x the 13-week average. Participation is around or above normal and provides reasonable confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.6112-week average 0.81
12-week confirmation
Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 19.5% over four weeks, -21.1% over 12 weeks, and 1296.5% over one year. The current trend has remained active for 44 consecutive weeks.
Performance by holding period
Active trend streak44 weeks
Active weeks in one year44
Trend breadth84.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.57Latest activity-pressure read.
Pressure change30.5%Four-week change in activity pressure.
Leadership96.66Latest relative-leadership reading.
RS change-2.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-39.3%Distance below the 52-week high.
13-week volatility10.5%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher17 of 269 weeks finished lower.
Best week+58.7%Week of 13 Mar.
Worst week-31.9%Week of 17 Apr.
Latest week+7.0%Week of 7 Aug.
Shape of recent returns
Strong gains15
Modest gains2
Flat weeks0
Modest losses3
Sharp losses6
Recent vol10.5%13-week weekly-return volatility.
Base vol23.6%52-week weekly-return volatility.
Up/down split30/22Count of positive and negative weeks in the 52-week window.
Average skew18.7% / -8.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNO Healthcare
4-week rank3 / 24
Group average4.3%
Trend breadth33.3%
Trend33.3%active weekly trend signals
MD37.5%positive activity pressure
RS29.2%positive relative leadership
Four-week leaders
IndustryNO Biotechnology
4-week rank3 / 11
Group average9.2%
Trend breadth36.4%
Trend36.4%active weekly trend signals
MD27.3%positive activity pressure
RS45.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape61/100
Trend, activity pressure, participation, and risk combine to a 61/100 tape read.
Indicator analysis69/100Latest 12-week confirmation: trend 12/12, activity pressure 3/12, relative leadership 12/12.
Activity pressure 0.61; No reversal markers Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Circio Holding ASA (0RIS) to Deliver Oral Presentation on circVec Platform at ESGCT 2026 in Hamburg Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 8.77 NOK | 7.0% | 6.71 NOK | 3.85 NOK | -0.57 | 96.66 | 25.5M | On |
| 31 Jul 2026 | 8.20 NOK | -11.4% | 6.46 NOK | 3.90 NOK | -0.69 | 91.18 | 23.4M | On |
| 24 Jul 2026 | 9.25 NOK | 19.8% | 6.23 NOK | 3.96 NOK | -0.76 | 124.26 | 24.3M | On |
| 17 Jul 2026 | 7.72 NOK | 5.2% | 5.96 NOK | 4.01 NOK | -0.88 | 99.85 | 12.9M | On |
| 10 Jul 2026 | 7.34 NOK | -7.6% | 5.74 NOK | 4.07 NOK | -0.82 | 99.37 | 12.9M | On |
| 3 Jul 2026 | 7.94 NOK | 4.3% | 5.54 NOK | 4.13 NOK | -0.71 | 122.02 | 5.6M | On |
| 26 Jun 2026 | 7.61 NOK | -8.9% | 5.31 NOK | 4.20 NOK | -0.56 | 126.40 | 3.2M | On |
| 19 Jun 2026 | 8.35 NOK | 2.3% | 5.10 NOK | 4.26 NOK | -0.36 | 151.97 | 10.2M | On |
| 12 Jun 2026 | 8.16 NOK | -3.1% | 4.86 NOK | 4.32 NOK | -0.15 | 151.80 | 7.6M | On |
| 5 Jun 2026 | 8.42 NOK | -6.4% | 4.62 NOK | 4.40 NOK | 0.12 | 170.58 | 5.0M | On |
| 29 May 2026 | 9.00 NOK | -0.2% | 4.37 NOK | 4.45 NOK | 0.32 | 203.95 | 29.0M | On |
| 22 May 2026 | 9.02 NOK | -18.9% | 4.11 NOK | 4.49 NOK | 0.46 | 214.92 | 46.8M | On |
| 15 May 2026 | 11.12 NOK | 16.8% | 3.84 NOK | 4.53 NOK | 0.63 | 316.22 | 47.8M | On |
| 8 May 2026 | 9.52 NOK | 1.2% | 3.51 NOK | 4.57 NOK | 0.82 | 294.20 | 38.3M | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.